X4 Pharmaceuticals (XFOR) Enterprise Value (QoQ) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | X4 Pharmaceuticals | 182.28 Mn | 182.28 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -211.71% |
| Sep 30, 2025 | -77.54% |
| Jun 30, 2025 | 2.58% |
| Mar 31, 2025 | 27.72% |
| Dec 31, 2024 | 42.82% |
| Sep 30, 2024 | 33.83% |
| Jun 30, 2024 | -143.36% |
| Mar 31, 2024 | 39.03% |
| Dec 31, 2023 | 24.60% |
| Sep 30, 2023 | 3.55% |
| Jun 30, 2023 | -46.06% |
| Mar 31, 2023 | 23.26% |
| Dec 31, 2022 | -52.42% |
| Sep 30, 2022 | -68.55% |
| Jun 30, 2022 | 28.68% |
| Mar 31, 2022 | 18.78% |
| Dec 31, 2021 | -7.06% |
| Sep 30, 2021 | 19.76% |
| Jun 30, 2021 | 17.18% |
| Mar 31, 2021 | -46.04% |
| Dec 31, 2020 | 11.38% |
| Sep 30, 2020 | 14.39% |
| Jun 30, 2020 | 9.83% |
| Mar 31, 2020 | 8.82% |
| Dec 31, 2019 | -65.49% |
| Sep 30, 2019 | 18.31% |
| Jun 30, 2019 | -318.60% |
| Mar 31, 2019 | -170.78% |
| Dec 31, 2018 | 16.74% |
| Sep 30, 2018 | 21.61% |
| Jun 30, 2018 | 80.30% |
| Mar 31, 2018 | -140.03% |
| Dec 31, 2017 | 14.94% |
| Sep 30, 2017 | 3.48% |
| Jun 30, 2017 | -738.38% |